Cancer Therapy News and Research

RSS

Study reveals key driver of metabolic rewiring in liver cancer cells

Cancer cells are chameleons. They completely change their metabolism to grow continuously. University of Basel scientists have discovered that high levels of the amino acid arginine drive metabolic reprogramming to promote tumor growth.

6 Oct 2023

Blood test for pan-cancer biomarker could revolutionize early cancer detection

Diagnostic tools for timely, accurate and inexpensive early cancer detection that can assess risk or monitor response to treatment could help patients get the care they need faster and improve existing care strategies.

5 Oct 2023

Unlocking the future of cancer care: Overcoming challenges in personalized neoantigen vaccine development

Challenges associated with the development and design of neoantigen cancer vaccines.

5 Oct 2023

NCI-sponsored cancer clinical trials become more representative of broader patient population

Compared to the year 2000, a greater proportion of NCI-sponsored early-phase clinical trial participants in 2022 were older, from minority racial/ethnic groups, and lived in historically underrepresented regions of the U.S., according to a study presented at the 16th AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved, held September 29-October 2, 2023.

29 Sep 2023

Small and precise CRISPR-Cas13bt3 system can be used to shred viruses

Small and precise: These are the ideal characteristics for CRISPR systems, the Nobel-prize winning technology used to edit nucleic acids like RNA and DNA.

27 Sep 2023

ACT and personalized cancer vaccine combo shows efficacy in ovarian cancer patients

A Ludwig Cancer Research study has shown that combining adoptive T cell therapy (ACT) with an innovative, personalized cancer vaccine under development at the Lausanne Branch of the Ludwig Institute for Cancer Research can benefit patients with late-stage, drug-resistant ovarian cancer.

21 Sep 2023

New cancer therapy shows promise in mouse models, slows or reverses tumor growth

A new cancer therapy developed by Purdue University researchers attacks tumors by tricking cancer cells into absorbing a snippet of RNA that naturally blocks cell division.

4 Sep 2023

The Clinical Importance of Circulating Tumor DNA

Cancer remains a leading killer among medical causes of death worldwide.

31 Aug 2023

Light-driven bacteria could be used to target and kill cancer cells

Targeting malignant tumors with high precision is challenging for biomedical researchers. However, this scenario is likely to witness a paradigm shift in the near future, through the use of specially engineered bacteria, that can eliminate malignant cells efficiently.

29 Aug 2023

The past, present, and future of cancer drug development

A new editorial paper was published in Oncoscience (Volume 10) on August 17, 2023, entitled, "Cancer drug development yesterday, today and tomorrow."

25 Aug 2023

Newly published ESC Guidelines provide comprehensive overview of acute coronary syndromes

The European Society of Cardiology (ESC) Guidelines on acute coronary syndromes are published online today in European Heart Journal.

25 Aug 2023

KAUST researchers refute challenges to targeted cancer therapy

Drugs that inhibit a key protein should offer new targeted cancer therapy for leukemia and breast cancer.

24 Aug 2023

Scientists find way to 'press self-destruct button' in gastric cancer associated with Epstein-Barr Virus

Now, scientists at The Wistar Institute have discovered a potential target for gastric cancers associated with Epstein-Barr Virus; study results were published in the journal mBio.

22 Aug 2023

SIO and ASCO recommend mindfulness-based interventions for anxiety, depression in cancer patients

The Society for Integrative Oncology (SIO) and the American Society of Clinical Oncology (ASCO) formally recommend mindfulness-based interventions (MBIs) and other integrative therapies to manage anxiety and depression symptoms in adults living with cancer.

16 Aug 2023

Cancer Therapy News and Research

Study reveals key driver of metabolic rewiring in liver cancer cells

Blood test for pan-cancer biomarker could revolutionize early cancer detection

Unlocking the future of cancer care: Overcoming challenges in personalized neoantigen vaccine development

NCI-sponsored cancer clinical trials become more representative of broader patient population

Small and precise CRISPR-Cas13bt3 system can be used to shred viruses

ACT and personalized cancer vaccine combo shows efficacy in ovarian cancer patients

New cancer therapy shows promise in mouse models, slows or reverses tumor growth

The Clinical Importance of Circulating Tumor DNA

Light-driven bacteria could be used to target and kill cancer cells

The past, present, and future of cancer drug development

Newly published ESC Guidelines provide comprehensive overview of acute coronary syndromes

KAUST researchers refute challenges to targeted cancer therapy

Scientists find way to 'press self-destruct button' in gastric cancer associated with Epstein-Barr Virus

SIO and ASCO recommend mindfulness-based interventions for anxiety, depression in cancer patients

Proton radiotherapy used for the first time in Switzerland to treat esophageal tumor

Unveiling hidden threats: clustering loops in CAR-T cells impact cancer therapy

New gene therapy shows promise for treating fusion-driven cancers

Gut microbiota could affect the responsiveness and efficacy of cancer treatment

Multifunctional Ga-based nanoparticles combine cancer phototherapy with immunotherapy

Nutrition meets cancer therapy: How gut microbiome and diet impact immunotherapy success

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News